0Studies tracked
0Claims cite
0Videos use
Average study score: 71/100
Bibliography
Studies by this author
2 studies attributed to Rohit Seth Loomba on the platform. Click a card to read the full analysis.
Study
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial
To investigate the efficacy and safety of once-weekly subcutaneous semaglutide 2.4 mg versus placebo in adults with biopsy-confirmed NASH-related compensated cirrhosis.
Study
Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.
This study evaluates whether IONIS-DGAT2Rx, an antisense oligonucleotide inhibitor of DGAT2, reduces liver fat in adults with type 2 diabetes and NAFLD.